Acute Respiratory Failure With Hypoxia
15
2
3
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.3%
2 terminated out of 15 trials
71.4%
-15.1% vs benchmark
13%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (15)
The Acute Respiratory Intervention StudiEs in Africa (ARISE-AFRICA) Study
PEEP in Patients With Acute Respiratory Failure
Physiologic Effects of Continuous Positive Airway Pressure and High Flow Nasal Oxygenation in Patients with Acute Respiratory Distress Syndrome.
PK of Piperacillin/Tazobactam in Adults Undergoing ECMO
Risk Stratification of COVID-19 Using Urine Biomarkers
Prehospital High-Flow Nasal Oxygen Therapy
pRotective vEntilation With Veno-venouS Lung assisT in Respiratory Failure
Supplemental Parenteral Nutrition in Pediatric Respiratory Failure
High-flow Oxygen Therapy vs Non-invasive Ventilation: Comparison of Alveolar Recruitment in Acute Respiratory Failure
Postoperative Respiratory Abnormalities
ARDS Caused by COVID-19
Severe ARDS: Generating Evidence
Conduct of Nasal High Flow Oxygen in Acute Respiratory Failure
Positive Pressure During Bronchoscopy
NAVA Helmet in Pediatric Respiratory Failure